Stefan Kommoss

Final validation of the ProMisE molecular classifier for endometrial carcinoma in a large population-based case series

Stefan Kommoss, Melissa K. McConechy, F. Kommoss et al. · Annals of Oncology · 2018 · 712 citations · Full text

Dose-Response Association of CD8⁺ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer

Ellen L. Goode, Matthew S. Block, Kimberly R. Kalli et al. · JAMA Oncology · 2017 · 388 citations · Full text

PORTEC-4a: international randomized trial of molecular profile-based adjuvant treatment for women with high-intermediate risk endometrial cancer

Anne Sophie V M van den Heerik, Nanda Horeweg, Remi A. Nout et al. · International Journal of Gynecological Cancer · 2020 · 235 citations · Full text

Simple versus Radical Hysterectomy in Women with Low-Risk Cervical Cancer

Marie Plante, Janice S. Kwon, Sarah E. Ferguson et al. · New England Journal of Medicine · 2024 · 221 citations · Full text

Dual loss of the <scp>SWI</scp>/<scp>SNF</scp> complex <scp>ATPases SMARCA4</scp>/<scp>BRG1</scp> and <scp>SMARCA2</scp>/<scp>BRM</scp> is highly sensitive and specific for small cell carcinoma of the ovary, hypercalcaemic type

Anthony N. Karnezis, Yemin Wang, Pilar Ramos et al. · The Journal of Pathology · 2015 · 218 citations · Full text